Baseline characteristics and effects of ten years of growth hormone (GH) replacement therapy in adults previously treated with pituitary irradiation

Growth Hormone and IGF Research

Volumn 23, Issue 6, 2013, Pages 249-255

  Elbornsson, Mariam ^a   Götherström, Galina ^a   Bengtsson, Bengt Åke ^a   Johannsson, Gudmundur ^a   Svensson, Johan ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Body composition; Bone mass; Glucose homeostasis; Growth hormone deficiency; Pituitary irradiation; Serum lipid pattern; Vascular events

Indexed keywords

GLUCOCORTICOID; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ADVERSE OUTCOME; ARTICLE; BODY COMPOSITION; BODY MASS; BONE MASS; BRAIN INFARCTION; CANCER RADIOTHERAPY; CAUSE OF DEATH; CONTROLLED STUDY; DIABETES MELLITUS; DOSIMETRY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GLUCOSE METABOLISM; GROWTH HORMONE DEFICIENCY; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO;

BODY COMPOSITION; BONE MASS; GLUCOSE HOMEOSTASIS; GROWTH HORMONE DEFICIENCY; PITUITARY IRRADIATION; SERUM LIPID PATTERN; VASCULAR EVENTS;

ABSORPTIOMETRY, PHOTON; ADULT; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GLUCOSE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; LIPIDS; MALE; MIDDLE AGED; PITUITARY IRRADIATION; PROGNOSIS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 84886099768     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2013.09.001     Document Type: Article

References (34)

1. Boelaert K., Gittoes N.J. Radiotherapy for non-functioning pituitary adenomas. Eur. J. Endocrinol. 2001, 144:569-575.
2. Gittoes N.J., Bates A.S., Tse W., et al. Radiotherapy for non-function pituitary tumours. Clin. Endocrinol. (Oxf.) 1998, 48:331-337.
3. Plowman P.N. Pituitary adenoma radiotherapy-when, who and how?. Clin. Endocrinol. (Oxf.) 1999, 51:265-271.
4. Appelman-Dijkstra N.M., Kokshoorn N.E., Dekkers O.M., et al. Pituitary dysfunction in adult patients after cranial radiotherapy: systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2011, 96:2330-2340.
5. Darzy K.H., Shalet S.M. Pathophysiology of radiation-induced growth hormone deficiency: efficacy and safety of GH replacement. Growth Hormon. IGF Res. 2006, 16(Suppl. A):S30-S40.
6. Darzy K.H., Shalet S.M. Hypopituitarism as a consequence of brain tumours and radiotherapy. Pituitary 2005, 8:203-211.
7. Maiter D., Abs R., Johannsson G., et al. Baseline characteristics and response to GH replacement of hypopituitary patients previously irradiated for pituitary adenoma or craniopharyngioma: data from the Pfizer International Metabolic Database. Eur. J. Endocrinol. 2006, 155:253-260.
8. Noad R., Narayanan K.R., Howlett T., Lincoln N.B., Page R.C. Evaluation of the effect of radiotherapy for pituitary tumours on cognitive function and quality of life. Clin. Oncol. (R. Coll. Radiol) 2004, 16:233-237.
9. Peace K.A., Orme S.M., Sebastian J.P., et al. The effect of treatment variables on mood and social adjustment in adult patients with pituitary disease. Clin. Endocrinol. (Oxf.) 1997, 46:445-450.
10. Armstrong G.T., Stovall M., Robison L.L. Long-term effects of radiation exposure among adult survivors of childhood cancer: results from the childhood cancer survivor study. Radiat. Res. 2010, 174:840-850.
11. Flickinger J.C., Nelson P.B., Taylor F.H., Robinson A. Incidence of cerebral infarction after radiotherapy for pituitary adenoma. Cancer 1989, 63:2404-2408.
12. Murros K.E., Toole J.F. The effect of radiation on carotid arteries. a review article. Arch. Neurol. 1989, 46:449-455.
13. Bulow B., Hagmar L., Mikoczy Z., Nordstrom C.H., Erfurth E.M. Increased cerebrovascular mortality in patients with hypopituitarism. Clin. Endocrinol. (Oxf.) 1997, 46:75-81.
14. Sherlock M., Ayuk J., Tomlinson J.W., et al. Mortality in patients with pituitary disease. Endocr. Rev. 2010, 31:301-342.
15. Svensson J., Bengtsson B.A., Rosen T., Oden A., Johannsson G. Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy. J. Clin. Endocrinol. Metab. 2004, 89:3306-3312.
16. Tomlinson J.W., Holden N., Hills R.K., et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 2001, 357:425-431.
17. Garmey E.G., Liu Q., Sklar C.A., et al. Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J. Clin. Oncol. 2008, 26:4639-4645.
18. Elbornsson M., Gotherstrom G., Bosaeus I., Bengtsson B.A., Johannsson G., Svensson J. Fifteen years of growth hormone (GH) replacement improves body composition and cardiovascular risk factors. Eur. J. Endocrinol. 2013.
19. Ho K.K. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur. J. Endocrinol. 2007, 157:695-700.
20. Molitch M.E., Clemmons D.R., Malozowski S., Merriam G.R., Vance M.L., Endocrine S. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011, 96:1587-1609.
21. Boland E.W. Antirheumatic effects of hydrocortisone (free alcohol), hydrocortisone acetate, and cortisone (free alcohol) as compared with cortisone acetate; results from oral administration in patients with rheumatoid arthritis. Br. Med. J. 1952, 1:559-564.
22. Johannsson G., Rosen T., Bengtsson B.A. Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults. Clin. Endocrinol. (Oxf.) 1997, 47:571-581.
23. Gotherstrom G., Bengtsson B.A., Bosaeus I., Johannsson G., Svensson J. Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency. Eur. J. Endocrinol. 2007, 156:55-64.
24. Mazess R.B., Barden H.S., Bisek J.P., Hanson J. Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am. J. Clin. Nutr. 1990, 51:1106-1112.
25. Bruce A., Andersson M., Arvidsson B., Isaksson B. Body composition. Prediction of normal body potassium, body water and body fat in adults on the basis of body height, body weight and age. Scand. J. Clin. Lab. Invest. 1980, 40:461-473.
26. Brabant G., von zur Muhlen A., Wuster C., et al. Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm. Res. 2003, 60:53-60.
27. Landin-Wilhelmsen K., Wilhelmsen L., Lappas G., et al. Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin. Endocrinol. (Oxf.) 1994, 41:351-357.
28. Svensson J., Johannsson G., Bengtsson B.A. Insulin-like growth factor-I in growth hormone-deficient adults: relationship to population-based normal values, body composition and insulin tolerance test. Clin. Endocrinol. (Oxf.) 1997, 46:579-586.
29. Gotherstrom G., Bengtsson B.A., Bosaeus I., Johannsson G., Svensson J. A 10-year, prospective study of the metabolic effects of growth hormone replacement in adults. J. Clin. Endocrinol. Metab. 2007, 92:1442-1445.
30. Gotherstrom G., Svensson J., Koranyi J., et al. A prospective study of 5years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices. J. Clin. Endocrinol. Metab. 2001, 86:4657-4665.
31. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18:499-502.
32. Reaven G.M. Pathophysiology of insulin resistance in human disease. Physiol. Rev. 1995, 75:473-486.
33. Burman P., Mattsson A.F., Johannsson G., et al. Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality. J. Clin. Endocrinol. Metab. 2013, 98:1466-1475.
34. Nilsson A.G., Svensson J., Johannsson G. Management of growth hormone deficiency in adults. Growth Hormon. IGF Res. 2007, 17:441-462.